Article: Persistence of SARS-CoV-2: a new paradigm of COVID-19 management.
Annali di igiene : medicina preventiva e di comunita
2021 Volume 33, Issue 5, Page(s) 426–432
Abstract: ... about the persistence of SARS-CoV-2 on various surfaces and in the respiratory system of patients who have survi-ved ... One of the most concerning issues since the emergence of the SARS-CoV-2 is persistence in patients and ... SARS-CoV-2 test in China, Japan, and South Korea. In addition to the persistence of the virus, SARS-CoV ...
| Abstract | Abstract: Full attention must be given to the follow-up of patients recovered from Coronavirus disease 2019, which developed in Wuhan, China in December 2019. Among the most serious issues since the emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 has been whether those who had it can experience a second episode of infection and what that implies for immunity. The earlier studies on COVID-19 disease focused primarily on the epidemiological, clinical, and radiological characteristics of patients with CO-VID-19. However, conclusions of these studies still require to be warranted by more careful design, larger sample size and statistically well structured studies. COVID-19 is an under-studied infection, and several aspects of viral transmission and clinical progress remain at present unclear. There is a concern about the persistence of SARS-CoV-2 on various surfaces and in the respiratory system of patients who have survi-ved. One of the most concerning issues since the emergence of the SARS-CoV-2 is persistence in patients and whether patients can be re-infected. After hospital discharge, recovered patients were reported to have positive SARS-CoV-2 test in China, Japan, and South Korea. In addition to the persistence of the virus, SARS-CoV-2 re-infection may occur in survivors. In this paper, we focused on the evidence of persistence and re-infection of SARS-CoV-2. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/prevention & control ; COVID-19/transmission ; COVID-19 Testing ; Communicable Disease Control/organization & administration ; Cytokine Release Syndrome/etiology ; Disease Reservoirs/virology ; Fomites/virology ; Host-Pathogen Interactions/immunology ; Humans ; Pandemics ; Recurrence ; SARS-CoV-2/immunology ; SARS-CoV-2/isolation & purification ; SARS-CoV-2/pathogenicity | |||||
| Language | English | |||||
| Publishing date | 2021-02-11 | |||||
| Publishing country | Italy | |||||
| Document type | Journal Article | |||||
| ZDB-ID | 1018045-x | |||||
| ISSN | 1120-9135 ; 0029-6287 | |||||
| ISSN | 1120-9135 ; 0029-6287 | |||||
| DOI | 10.7416/ai.2021.2414 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 2845: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.